Richard Scranton, Chief Scientific Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 1,367 shares at $33.02 ($45K) on 2018-06-04, disclosed to the SEC on 2018-06-06.
Open-market sale of $45k PCRX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2019-06-05 | $670K | — | Filing → |